Erratum: Risk assessment in patients with an acute ST-elevation myocardial infarction (Journal of Comparative Effectiveness Research (2016) 5:6 (581-593) DOI: 10.2217/cer-2016-0017);Risk assessment in patients with an acute ST-elevation myocardial infarction

Journal of Comparative Effectiveness Research

Volumn 5, Issue 6, 2016, Pages 581-593

  Ahmed, Nadeem ^a,b   Carberry, Jaclyn ^a,b   Teng, Vannesa ^a,b   Carrick, David ^a,b   Berry, Colin ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

cardiac MRI; cardiology cardiovascular; coronary angiography; echocardiography; evidence based medicine; invasive hemodynamics; plasma biomarkers; risk assessment; risk scoring; STEMI

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; GALECTIN 3; MYELOPEROXIDASE; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; AGE; CARDIAC IMAGING; CARDIOGENIC SHOCK; CARDIOVASCULAR MAGNETIC RESONANCE; CENTRAL VENOUS PRESSURE; CLINICAL FEATURE; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GLASGOW COMA SCALE; GRACE SCORE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HEART RIGHT VENTRICLE PRESSURE; HEART RUPTURE; HEART VENTRICLE THROMBOSIS; HEART VENTRICULOGRAPHY; HUMAN; KILLIP CLASSIFICATION; LEFT VENTRICULAR THROMBUS; NO REFLOW PHENOMENON; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; T2 WEIGHTED EDEMA IMAGING; DIAGNOSTIC IMAGING; EMERGENCY HEALTH SERVICE; HEART INFARCTION;

CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; HUMANS; MYOCARDIAL INFARCTION; RISK ASSESSMENT; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 84992111538     PISSN: 20426305     EISSN: 20426313     Source Type: Journal    
DOI: 10.2217/cer-2016-0017e1     Document Type: Erratum

References (76)

1. Steg G, James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur. Heart J. 22, 2569-2619 (2012).
2. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am. J. Med. 124, 40-47 (2011).
3. Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L. Association between adoption of evidencebased treatment and survival for patients with ST-elevation myocardial infarction. J. Am. Med. Assoc. 305, 1677-1684 (2011).
4. Roger VL, Go AS, Lloyd-Jones DM et al. Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125, 188-197 (2012).
5. Fox KA, Carruthers KF, Dunbar DR et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur. Heart J. 31, 2755-2764 (2010).
6. Park HW, Yoon CH, Kang SH et al. Early-and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-STsegment elevation myocardial infarction. Int. J. Cardiol. 169, 254-261 (2013).
7. Pedersen F, Butrymovich V, Kelbæk H et al. Short-and longterm cause of death in patients treated with primary PCI for STEMI. J. Am. Coll. Cardiol. 64(20), 2101-2108 (2014).
8. Benamer H, Tafflet M, Bataille S et al.; CARDIO-ARHIF Registry Investigators. Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI Registry. EuroIntervention 6, 1073-1079 (2011).
9. Kytö V, Sipilä J, Rautava P. Gender and in-hospital mortality of ST-segment elevation myocardial infarction (from a multihospital nationwide registry study of 31,689 patients). Am. J. Cardiol. 115(3), 303-306 (2015).
10. Steg PG, Dabbous OH, Feldman LJ et al.; Global Registry of Acute Coronary Events Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109(4), 494-499 (2004).
11. Trzeciak P, Gierlotka M, Gasior M et al. Mortality of patients with ST-segment elevation myocardial infarction and cardiogenic shock treated by PCI is correlated to the infarct-related artery - results from the PL-ACS Registry. Int. J. Cardiol. 166, 193-197 (2013).
12. Noman A, Balasubramaniam K, Das R et al. Admission heart rate predicts mortality following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an observational study. Cardiovasc. Ther. 31(6), 363-369 (2013).
13. Engström AE, Vis MM, Bouma BJ et al. Mitral regurgitation is an independent predictor of 1-year mortality in STelevation myocardial infarction patients presenting in cardiogenic shock on admission. Acute Card. Care 12(2), 51-57 (2010).
14. Lettieri C, Savonitto S, De Servi S et al. Emergency percutaneous coronary intervention in patients with STelevation myocardial infarction complicated by out-ofhospital cardiac arrest: early and medium-term outcome. Am. Heart J. 157(3), 569-575 (2009).
15. Pan W, Yang SS, Wang LF et al. Outcome of patients with ST-elevation myocardial infarction complicated by prehospital cardiac arrest underwent emergency percutaneous coronary intervention. Zhonghua Xin Xue Guan Bing Za Zhi 38(10), 875-879 (2010).
16. de Waha S, Eitel I, Desch S et al. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: a substudy of the AIDA STEMI trial. Eur. Heart J. Acute Cardiovasc. Care. doi:10.1177/2048872615624240 (2015) (Epub ahead of print).
17. Bedotto JB, Kahn JK, Rutherford BD et al. Failed direct coronary angioplasty for acute myocardial infarction: in-hospital outcome and predictors of death. J. Am. Coll. Cardiol. 22(3), 690-694 (1993).
18. Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). Am. J. Cardiol. 106(3), 342-347 (2010).
19. Claessen BE, van der Schaaf RJ, Verouden NJ et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovasc. Interv. 2(11), 1128-1134 (2009).
20. Claessen BE, Dangas GD, Weisz G et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur. Heart J. 33(6), 768-775 (2012).
21. Keeley EC, Mehran R, Brener SJ et al. Impact of multiple complex plaques on short-and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial). Am. J. Cardiol. 113(10), 1621-1627 (2014).
22. Dreyer RP, Beltrame JF, Neil C et al. Cardiac hemodynamics in men versus women during acute ST-segment elevation myocardial infarction. Am. J. Cardiol. 112(2), 143-149 (2013).
23. Bagai A, Armstrong PW, Stebbins A et al. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for STsegment elevation myocardial infarction: findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. Am. Heart J. 166(5), 913-919 (2013).
24. Planer D, Mehran R, Witzenbichler B et al. Prognostic utility of left ventricular end-diastolic pressure in patients with STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am. J. Cardiol. 108(8), 1068-1074 (2011).
25. Stone GW, Cox D, Garcia E et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 104(6), 636-641 (2001).
26. Gigliotti OS, Babb JD, Dieter RS et al.; Society for Cardiovascular Angiography and Interventions. Optimal use of left ventriculography at the time of cardiac catheterization: a consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter. Cardiovasc. Interv. 85(2), 181-191 (2015).
27. Joffe SW, Ferrara J, Chalian A, Tighe DA, Aurigemma GP, Goldberg RJ. Are ejection fraction measurements by echocardiography and left ventriculography equivalent? Am. Heart J. 158(3), 496-502 (2009).
28. Gibson CM, Cannon CP, Daley WL et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93(5), 879-888 (1996).
29. Brodie BR, Stuckey TD, Hansen C, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am. J. Cardiol. 85(1), 13-18 (2000).
30. Kammler J, Kypta A, Hofmann R et al. TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin. Res. Cardiol. 98(3), 165-170 (2009).
31. DeGeare VS, Stone GW, Grines L et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am. J. Cardiol. 86(1), 30-34 (2000).
32. Cura FA, L'Allier PL, Kapadia SR et al. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am. J. Cardiol. 88(2), 124-128 (2001).
33. Halkin A, Singh M, Nikolsky E et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J. Am. Coll. Cardiol. 45(9), 1397-1405 (2005).
34. Gibson CM, Cannon CP, Murphy SA et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101(2), 125-130 (2000).
35. Gibson CM, Kirtane AJ, Morrow DA et al. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate-to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECTTIMI 30). Am. Heart J. 152(4), 756-761 (2006).
36. Gibson CM, Pride YB, Buros JL et al. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 51(5), 546-551 (2008).
37. Payne AR, Berry C, Doolin O et al. Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. J. Am. Heart Assoc. 1(4), e002246 (2012).
38. McGeoch R, Watkins S, Berry C et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc. Interv. 3(7), 715-722 (2010).
39. Fearon WF, Low AF, Yong AS et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation 127(24), 2436-2441 (2013).
40. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation 113(17), 2054-2061 (2006).
41. Cuculi F, Dall'Armellina E, Manlhiot C et al. Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction. Eur. Heart J. 35(29), 1971-1980 (2014).
42. van de Hoef TP, van Lavieren MA, Damman P et al. Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circ. Cardiovasc. Interv. 7(3), 301-311 (2014).
43. van't Hof AW, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 350(9078), 615-619 (1997).
44. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J. Am. Coll. Cardiol. 38(2), 478-485 (2001).
45. Ohman EM, Armstrong PW, Christenson RH et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N. Engl. J. Med. 335(18), 1333-1341 (1996).
46. Rakowski T, Dziewierz A, Legutko J et al. Creatine kinase-MB assessed in patients with acute myocardial infarction correlates with cardiac magnetic resonance infarct size at 6-month follow up. Hellenic J. Cardiol. 55(1), 4-8 (2014).
47. Mayr A, Mair J, Schocke M et al. Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function. Int. J. Cardiol. 147(1), 118-123 (2011).
48. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int. J. Cardiol. 109(2), 248-256 (2006).
49. Makrygiannis SS, Ampartzidou OS, Zairis MN et al. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acutemyocardial infarction. Am. J. Cardiol. 111(1), 26-30 (2013).
50. Brennan ML, Penn MS, Van Lente F et al. Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349(17), 1595-1604 (2003).
51. Stankovic S, Asanin M, Majkic-Singh N et al. The usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Clin. Lab. 58(1-2), 125-131 (2012).
52. Yu X, Sun Y, Zhao Y et al. Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure. Int. Heart J. 56(3), 314-318 (2015).
53. Milner TD, Viner AC, MacKinnon AC, Sethi T, Flapan AD. Temporal expression of galectin-3 following myocardial infarction. Acta Cardiol. 69(6), 595-602 (2014).
54. de Araújo Gonçalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur. Heart J. 26(9), 865-872 (2005).
55. Eggers KM, Kempf T, Venge P, Wallentin L, Wollert KC, Lindahl B. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. Am. Heart J. 160(1), 88-94 (2010).
56. Quiñones MA. risk stratification after myocardial infarction clinical science versus practice behavior. Circulation 95, 1352-1354 (1997).
57. Vakili H, Sadeghi R, Rezapoor P, Gachkar L. In-hospital outcomes after primary percutaneous coronary intervention according to left ventricular ejection fraction. ARYA Atheroscler. 10(4), 211-217 (2014).
58. Wita K, Filipecki A, Lelek M et al. Prediction of left ventricular remodeling in patients with STEMI treated with primary PCI: use of quantitative myocardial contrast echocardiography. Coron. Artery Dis. 22(3), 171-178 (2011).
59. Cimino S, Canali E, Petronilli V et al. Global and regional longitudinal strain assessed by two-dimensional speckle tracking echocardiography identifies early myocardial dysfunction and transmural extent of myocardial scar in patients with acute ST elevation myocardial infarction and relatively preserved LV function. Eur. Heart J. Cardiovasc. Imag. 14(8), 805-811 (2013).
60. Joyce E, Hoogslag GE, Leong DP et al. Association between left ventricular global longitudinal strain and adverse left ventricular dilatation after ST-segment-elevation myocardial infarction. Circ. Cardiovasc. Imag. 7(1), 74-81 (2014).
61. Munk K, Andersen NH, Nielsen SS et al. Global longitudinal strain by speckle tracking for infarct size estimation. Eur. J. Echocardiogr. 12(2), 156-165 (2011).
62. McKay RG, Pfeffer MA, Pasternak RC et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 74(4), 693-702 (1986).
63. Brzezińska B, Loboz-Grudzień K, Sokalski L. Patterns of post-MI left ventricular volume changes - clinical implications. Kardiol. Pol. 65(10), 1190-1198 (2007).
64. Bolognese L, Neskovic AN, Parodi G et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 106(18), 2351-2357 (2002).
65. Gianstefani S, Douiri A, Delithanasis I et al. Incidence and predictors of early left ventricular thrombus after STelevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention. Am. J. Cardiol. 113(7), 1111-1116 (2014).
66. Garber AM, Mentz RJ, Al-Khalidi HR et al. Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarction. J. Thromb. Thrombolysis 41(3), 365-373 (2015).
67. Crawford TC, Smith WT, Velazquez EJ, Taylor SM, Jollis JG, Kisslo J. Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death. Am. J. Cardiol. 93(4), 500-503 (2004).
68. Visser CA, Kan G, Meltzer RS, Koolen JJ, Dunning AJ. Incidence, timing and prognostic value of left ventricular aneurysm formation after myocardial infarction: a prospective, serial echocardiographic study of 158 patients. Am. J. Cardiol. 57(10), 729-732 (1986).
69. Aletras AH, Tilak GS, Natanzon A et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 113(15), 1865-1870 (2006).
70. Eitel I, Desch S, Fuernau G et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J. Am. Coll. Cardiol. 55(22), 2470-2479 (2010).
71. Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97, 765-772 (1998).
72. van Kranenburg M, Magro M, Thiele H et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc. Imaging 7(9), 930-939 (2014).
73. Carrick D, Haig C, Rauhalammi S et al. Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur. Heart J. 37(13), 1044-1059 (2015).
74. Carrick D, Haig C, Ahmed N et al. Temporal evolution of myocardial hemorrhage and edema in patients after acute STsegment elevation myocardial infarction: pathophysiological insights and clinical implications. J. Am. Heart Assoc. 5(2), 1-13 (2016).
75. Ganame J, Messalli G, Dymarkowski S et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur. Heart J. 30(12), 1440-1449 (2009).
76. Eitel I, Friedrich MG. T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J. Cardiovasc. Magn. Reson. 13, 13 (2011).